Class II recall: American Regent, Inc.: AMINAOCAPROIC ACID INJECTION, USP, 250 mg/mL (5 g/20 mL), packaged in a) 20 mL M
American Regent, Inc. has issued a Class II recall for Aminocaproic Acid Injection, USP, 250 mg/mL (5 g/20 mL), distributed in 20 mL multiple dose vials (NDC 0517-9120-01) and 25x20 mL multiple dose vial packs (NDC 0517-9120-25). According to the recall notice, the product was found to be contaminated with particulate matter identified as hair, glass, and/or paraformaldehyde.
Most relevant for: Patients undergoing cardiac surgery or procedures requiring aminocaproic acid for hemostasis who may have received the contaminated product from the affected lot.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More cardiology updates
- OCEANIC-STROKE: Asundexian Not Linked to More Major BleedingOct 13, 2026
- ACC Statement Backs Whole-Food Diets Over Isolated NutrientsSep 30, 2026
- Oral GLP-1 drug orforglipron meets cardiovascular non-inferiority vs insulin glargineSep 30, 2026
- Stroke center status skews TAVR stroke rates in national registrySep 29, 2026
- Retatrutide produces substantial weight loss in phase 3 diabetes trialSep 29, 2026